Seit meiner Anfrage vom 15.08.00 bei einem Kurs von 7,45 EURO hat sich der Kurs trotz CHAOTISCHER MARKTLAGE bis dato VERDOPPELT. Schlußstand heute 15,30 EURO
tonlinechart1.teledata.de/informer2/...hwidth=&charttype=&gd1" style="max-width:560px" >
Und jetzt zu den Fakten ab dem 8 Nov. wird, -so denke ich auf- der Internationalen Gesundheitskonferenz in New York etwas spektakuläres veröffentlich werden.:Schaut euch die Umsätze in den letzten Wochen trotz des schlechten Umfeldes an!!
Friday October 27, 8:00 am Eastern Time
Press Release
SOURCE: Scios Inc.
Scios Announces Schedule for Webcasts of Upcoming Events
SUNNYVALE, Calif., Oct. 27 /PRNewswire/ -- Scios Inc. (Nasdaq: SCIO - news) announced that it will present at the Prudential Vector Healthcare Conference in New York City at 9:30 a.m. (ET) on Wednesday, November 8, 2000. This presentation will also be available to media, investors and the general public, pursuant to a new regulation issued by the Securities and Exchange Commission, Regulation FD. At this meeting, Scios management plans to outline the Company's strategy and plan for 2001. The presentation is expected to last approximately one-half hour. To access the audio webcast, go to
www.PrudentialSecurities.com. At this site, click on the icon for the Healthcare Conference, and then upon Scios Inc. The webcast will be available live on November 8th, as well as on-demand, beginning November 13th.
In other news, Scios will announce the results of the VMAC Phase III clinical trial at the American Heart Association meeting on November 15, 2000. The announcement will be followed by a webcast and conference call beginning at 12:30 PM (CT) with the investment community and Richard Brewer, CEO, Darlene Horton, M.D., Vice President of Medical Affairs, David Gryska, CFO, and Dr. James B. Young, M.D., Head, Section of Heart Failure and Cardiac Transplant Medicine at The Cleveland Clinic Foundation. The live audio and slide presentation will be broadcast over the Internet and will be available to members of the news media, investors and the general public. To access this event, go to Scios' website,
www.sciosinc.com, and click on the Investor Relations button. At the Investor Relations section, click on the Upcoming Events link, and then click on the Scios American Heart Association Presentation (link to vcall).
The telephone conference call can be accessed at 800-810-0924. A replay of the conference call will be available at 888-203-1112, confirmation code 523638. The replay will be available until November 22nd. The conference call is expected to last until 2:00 p.m. (CT).
Scios Inc.
Scios is a biopharmaceutical company engaged in the discovery, development, and commercialization of novel human therapeutics. Scios has commercial or research and development relationships with Chiron Corporation, DuPont Pharmaceuticals Company; Eli Lilly and Company; GenVec, Inc.; Kaken Pharmaceutical Co., Ltd.; and Novo Nordisk A/S, of Denmark. Additional information on Scios is available at its web site located at
www.sciosinc.com and in the company's various filings with the Securities and Exchange Commission.
The statements in this press release that are not historical facts are forward-looking statements that involve risks and uncertainties. These include the risks concerning the success of the VMAC trial and regulatory approval of Natrecor, as well as other risks detailed from time to time in the reports filed by Scios with the SEC, including the company's annual report on form 10-K for the year ended December 31, 1999 and subsequent reports on form 10-Q.
SOURCE: Scios Inc.
Wenn das Allzeithoch von 13,50 DOLLAR überwunden wird ist der Weg nach oben frei. Aber vorsicht am Montag werden hier die Kurse event. noch ein wenig nachgeben.( Euro - Dollar Verhältnis )
Gruß laser
Im übrigen Kicky: ich bin Laser und laser ( groß und kleinschreibung tut beim einloggen nichts zur Sache)Wer North-West ist hätte mich auch mal zwecks Info interessiert ( kannst Du glauben oder nicht- egal)
